Coeptis Therapeutics Stock Price on November 7, 2024
| COEP Stock | USD 0.20 0.01 5.26% |
If you're considering investing in Coeptis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Coeptis Therapeutics stands at 0.20, as last reported on the 30th of November, with the highest price reaching 0.21 and the lowest price hitting 0.19 during the day. Currently, Coeptis Therapeutics is extremely dangerous. Coeptis Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0201, which signifies that the company had a 0.0201% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Coeptis Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Coeptis Therapeutics' mean deviation of 2.75, and Risk Adjusted Performance of 0.0235 to double-check if the risk estimate we provide is consistent with the expected return of 0.0825%.
At this time, Coeptis Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 11/30/2024, Liabilities And Stockholders Equity is likely to grow to about 9.6 M, while Capital Stock is likely to drop 3,179. . At this time, Coeptis Therapeutics' Price To Sales Ratio is relatively stable compared to the past year. As of 11/30/2024, Price Earnings To Growth Ratio is likely to grow to 0.01, while Price To Operating Cash Flows Ratio is likely to drop (2.92). Coeptis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Coeptis |
Sharpe Ratio = 0.0201
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | COEP | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.11 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Coeptis Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Coeptis Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.6704 | Enterprise Value Ebitda (0.64) | Price Sales 45.681 | Shares Float 29.2 M | Wall Street Target Price 3 |
Coeptis Therapeutics Main Headline on 7th of November 2024
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for CO... by finance.yahoo.com
Coeptis Therapeutics Holdings, Inc. , a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced that results from their Phase 1 study evaluating DVX201, an allogeneic natural killer cell therapy, for the treatment of patients hospitalized with COVID-19 has been accepted for publication in Molecular Therapy Methods and Clinical Development.
Coeptis Therapeutics Valuation on November 7, 2024
It is possible to determine the worth of Coeptis Therapeutics on a given historical date. On November 7, 2024 Coeptis was worth 0.22 at the beginning of the trading date compared to the closed value of 0.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Coeptis Therapeutics stock. Still, in general, we apply an absolute valuation method to find Coeptis Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Coeptis Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Coeptis Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.20 | 0.21 | 0.20 | 0.21 | 81,527 | |
11/07/2024 | 0.22 | 0.22 | 0.18 | 0.21 | 1,106,037 |
| 0.20 | 0.21 | 0.19 | 0.20 | 106,826 |
| Backtest Coeptis Therapeutics | | | Coeptis Therapeutics History | | | Coeptis Therapeutics Valuation | Previous | Next |
Coeptis Therapeutics Trading Date Momentum on November 7, 2024
| On November 08 2024 Coeptis Therapeutics was traded for 0.20 at the closing time. The top price for the day was 0.21 and the lowest listed price was 0.19 . The trading volume for the day was 106.8 K. The trading history from November 8, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.76% . The overall trading delta against the current closing price is 0.00% . |
Coeptis Therapeutics Fundamentals Correlations and Trends
By evaluating Coeptis Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Coeptis Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Coeptis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Coeptis Therapeutics Stock history
Coeptis Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Coeptis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Coeptis Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Coeptis Therapeutics stock prices may prove useful in developing a viable investing in Coeptis Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.4 M | 12.6 M | |
| Net Loss | -33.8 M | -32.1 M |
Coeptis Therapeutics Stock Technical Analysis
Coeptis Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Coeptis Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Coeptis Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Coeptis Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Coeptis Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Coeptis Therapeutics shares will generate the highest return on investment. By undertsting and applying Coeptis Therapeutics stock market strength indicators, traders can identify Coeptis Therapeutics entry and exit signals to maximize returns
Coeptis Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Coeptis Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Coeptis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Coeptis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0235 | |||
| Jensen Alpha | 0.0934 | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.45) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.